Cannabis Watch: Curaleaf’s strong quarter sets it up for a better-than-expected year — and that’s without sales in New York and New Jersey

Curaleaf Holdings Inc.'s stronger-than-expected first-quarter earnings have put the company on track to deliver above-consensus numbers for 2021 and beat its own guidance for full-year revenue of $1.2 billion to $1.3 billion, analysts said Tuesday.